Is the United States an outlier in health care and health outcomes? A preliminary analysis
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
U.S. health care is often seen as an outlier, with high costs and only middling outcomes. This view implies a household production function for health, with both health care and lifestyle serving as inputs. Building on earlier work by Miller and Frech (2004), we make this argument explicit by estimating a production function from augmented OECD data. This allows us to determine whether the U.S. is literally an outlier; which turns on whether the United States is very far off the production surface. We find that the Unites States is somewhat less productive than the average OECD country, but that a substantial part of the observed difference results from poor lifestyle choices, particularly obesity.
- Allison, D. B. et al. (1999). “Annual Deaths Attributable to Obesity in the United States.” Journal of the American Medical Association 282(16), 1530–1538. CrossRef
- Andersen, G. F., U. Reinhardt, P.S. Hussey and V. Petrosyan. (2003). “It’s the Prices, Stupid: Why the United States is so Different From Other Countries.” Health Affairs 22(3), 89–105.
- Belsley, D.A., E. Kuh, and R.E. Welsch. (1980). Regression Diagnostics. New York: John Wiley.
- Chou, S.-Y., M. Grossman and H. Saffer. (2002). “An Economic Analysis of Adult Obesity: Results from the Behavioral Risk Factor Surveillance System.” National Bureau of Economic Research, Working Paper 9247.
- Cutler and D. M. (1994). “A Guide to Health Care Reform.” The Journal of Economic Perspectives 8, 13–29.
- Danzon, P. M. and A. Percy. (1995). “The Effects of Price Regulation on Productivity in Pharmaceuticals.” unpublished paper, The Wharton School, University of Pennsylvania.
- Deaton A. (2003). “Health, Inequality, and Economic Development.” Journal of Economic Literature XLI(1), 113–158.
- Duan N. (1983). “Smearing Estimate: A Nonparametric Retransformation Method.” Journal of the American Statistical Association 78, 605–610.
- Finkelstein, E. A., I. C. Fiebelkorn and G. Wang. (2003). “National Medical Spending Attributable to Overweight and Obesity: How Much and Who’s Paying?” Health Affairs: Web Exclusive.
- Frech, H. E., III, and R. D. Miller, Jr. (1999). The Productivity of Health Care and Pharmaceuticals: An International Comparison. Washington, DC: AEI Press.
- Huber, R. J. (1977). “The Behavior of Maximum Likelihood Methods under Nonstandard Conditions.” In Proceedings of Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley: University of California Press, pp. 221–33.
- Marmot M. (2005). The Status Syndrome: How Social Standing Affects Our Health and Longevity. New York: Owl Books.
- Miller, R. D., and H. E. Frech III. (2004). Health Care Matters: Pharmaceuticals, Obesity, and Quality of Life. Washington, DC: AEI Press.
- Mokdad, A. H., et al. (1999). “The Spread of the Obesity Epidemic in the United States, 1991–1998.” Journal of the American Medical Association 282(16), 1519–1522. CrossRef
- Must, A., et al. (1999). “The Disease Burden Associated with Overweight and Obesity.” Journal of the American Medical Association 282(16), 1523–1529. CrossRef
- O’Rourke and N. Iammarino. (2002). “The Future of Health Care Reform in the United States: Lessons from Abroad,” Review of Pharmacoeconomics and Outcomes Research.
- Organization of Economic Cooperation and Development (2000). OECD Health Data 2000: A Comparative Analysis of 29 Countries. Paris: OECD.
- Pauly and M. V. (1993). “U.S. Health Care Costs: The Untold Story,” Health Affairs 12(3), 152–159.
- Philipson, T. J. and R. A. Posner. (1999). The Long-Run Growth of Obesity as a Function of Technological Change, unpublished paper, University of Chicago, Harris School of Public Policy.
- Peltzman S. (1975). ”The Effects of Automobile Safety Regulation.” Journal of Political Economy 83(4), 677–726.
- Poterba, J. M. (1994). “A Skeptic’s View of Global Budget Caps,” The Journal of Economic Perspectives 8, 67–73.
- Stampfer, M. J., F. B. Hue, J. E. Manson, E. B. Rimm and W. C. Willet. (2000). “Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle.” New England Journal of Medicine 343, 16–22. CrossRef
- Sturm R. (2002). “The Effects of Obesity, Smoking and Drinking on Medical Problems and Costs.” Health Affairs 21(2), 245–253. CrossRef
- Szuba T. J. (1986). “International Comparison of Drug Consumption: Impact of Prices.” Social Science and Medicine 22(10), 1019–1025.
- Thorpe, K. E., C.S. Florence, D. H. Howard and P. Joski. (2005). “The Rising Prevalence of Treated Disease: Effects on Private Health Insurance Spending.” Health Affairs-Web Edition, W5-317–W5.325.
- White, H. (1980). “A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity,” 48, 817–838.
- Is the United States an outlier in health care and health outcomes? A preliminary analysis
International Journal of Health Care Finance and Economics
Volume 6, Issue 1 , pp 3-23
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Health production
- U.S. health care
- Comparative health care systems
- Industry Sectors
- Author Affiliations
- 1. Department of Economics, University of California, Santa Barbara, CA, 93106
- 2. Department of Health Services, School of Public Health, University of California, Los Angeles, CA, 90024
- 3. LNU-MSU College of International Business, Missouri State University, Dalian, 116029, China